Search research articles
Contact Us
Filters
Showing results (221-230 of 306) with videos related to
Page
of 31
Sort By:
Journal of Global Antimicrobial Resistance
|
July 23, 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors
Samantha Andreis, Monica Basso, Renzo Scaggiante, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 28, 2014
Antiretroviral therapy effects on sources of cortical rhythms in HIV subjects: responders vs. mild responders
Claudio Babiloni, Alfredo Pennica, Fabrizio Vecchio, et al.
Virus Genes
|
February 24, 2019
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice
Claudia Alteri, Rossana Scutari, Ada Bertoli, et al.
Antiviral Therapy
|
September 23, 2017
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice
Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, et al.
Antimicrobial Agents and Chemotherapy
|
May 19, 2010
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors
Francesca Ceccherini-Silberstein, Kurt Van Baelen, Daniele Armenia, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
March 18, 2014
Cortical sources of resting-state EEG rhythms in "experienced" HIV subjects under antiretroviral therapy
Claudio Babiloni, Paola Buffo, Fabrizio Vecchio, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 30, 2016
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
Mauro Zaccarelli, Maria Mercedes Santoro, Daniele Armenia, et al.
Antiviral Research
|
February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro
Valentina Svicher, Emanuela Balestra, Valeria Cento, et al.
The American Journal of Gastroenterology
|
June 20, 2006
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?
Alessia Ciancio, Antonina Smedile, Chiara Giordanino, et al.
The Journal of Antimicrobial Chemotherapy
|
January 25, 2020
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
Cathia Soulie, Maria Mercedes Santoro, Alexandre Storto, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 306) with videos related to
Sort By:
Page
of 31
Journal of Global Antimicrobial Resistance
|
July 23, 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors
Samantha Andreis, Monica Basso, Renzo Scaggiante, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 28, 2014
Antiretroviral therapy effects on sources of cortical rhythms in HIV subjects: responders vs. mild responders
Claudio Babiloni, Alfredo Pennica, Fabrizio Vecchio, et al.
Virus Genes
|
February 24, 2019
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice
Claudia Alteri, Rossana Scutari, Ada Bertoli, et al.
Antiviral Therapy
|
September 23, 2017
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice
Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, et al.
Antimicrobial Agents and Chemotherapy
|
May 19, 2010
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors
Francesca Ceccherini-Silberstein, Kurt Van Baelen, Daniele Armenia, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
March 18, 2014
Cortical sources of resting-state EEG rhythms in "experienced" HIV subjects under antiretroviral therapy
Claudio Babiloni, Paola Buffo, Fabrizio Vecchio, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 30, 2016
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
Mauro Zaccarelli, Maria Mercedes Santoro, Daniele Armenia, et al.
Antiviral Research
|
February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro
Valentina Svicher, Emanuela Balestra, Valeria Cento, et al.
The American Journal of Gastroenterology
|
June 20, 2006
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?
Alessia Ciancio, Antonina Smedile, Chiara Giordanino, et al.
The Journal of Antimicrobial Chemotherapy
|
January 25, 2020
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
Cathia Soulie, Maria Mercedes Santoro, Alexandre Storto, et al.
Page
of 31